tiprankstipranks
Trending News
More News >
Geratherm Medical AG (GB:0EL9)
LSE:0EL9
UK Market

Geratherm Medical (0EL9) Ratios

Compare
0 Followers

Geratherm Medical Ratios

GB:0EL9's free cash flow for Q4 2023 was €0.80. For the 2023 fiscal year, GB:0EL9's free cash flow was decreased by € and operating cash flow was €0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
6.57 6.57 2.33 2.73 2.96
Quick Ratio
4.39 4.39 1.31 1.80 1.84
Cash Ratio
2.46 2.46 0.27 0.62 0.59
Solvency Ratio
0.17 0.17 0.13 0.21 0.11
Operating Cash Flow Ratio
0.73 0.73 0.11 0.50 0.22
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.32 1.22 0.75
Net Current Asset Value
€ 8.68M€ 8.68M€ 3.68M€ 5.33M€ 6.70M
Leverage Ratios
Debt-to-Assets Ratio
0.24 0.24 0.27 0.28 0.23
Debt-to-Equity Ratio
0.42 0.42 0.50 0.50 0.39
Debt-to-Capital Ratio
0.29 0.29 0.33 0.33 0.28
Long-Term Debt-to-Capital Ratio
0.29 0.29 0.24 0.25 0.21
Financial Leverage Ratio
1.72 1.72 1.87 1.77 1.68
Debt Service Coverage Ratio
15.26 15.26 0.74 1.02 0.80
Interest Coverage Ratio
7.73 7.73 4.12 11.41 4.53
Debt to Market Cap
0.34 0.34 0.21 0.18 0.17
Interest Debt Per Share
1.74 1.74 1.91 2.10 1.62
Net Debt to EBITDA
0.17 0.17 3.21 1.22 1.41
Profitability Margins
Gross Profit Margin
24.68%24.68%66.24%64.07%68.93%
EBIT Margin
7.40%7.40%1.96%11.06%6.39%
EBITDA Margin
13.04%13.04%8.92%15.83%12.97%
Operating Profit Margin
5.36%5.36%2.39%11.07%5.28%
Pretax Profit Margin
6.63%6.63%1.25%9.90%5.23%
Net Profit Margin
3.96%3.96%1.35%7.45%1.46%
Continuous Operations Profit Margin
4.27%4.27%1.35%7.13%1.46%
Net Income Per EBT
59.71%59.71%108.13%75.21%27.93%
EBT Per EBIT
123.60%123.60%52.17%89.47%98.91%
Return on Assets (ROA)
2.67%2.67%0.96%5.68%0.87%
Return on Equity (ROE)
4.58%4.58%1.80%10.07%1.46%
Return on Capital Employed (ROCE)
3.98%3.98%2.26%10.79%4.00%
Return on Invested Capital (ROIC)
2.52%2.52%2.18%6.73%1.03%
Return on Tangible Assets
3.00%3.00%1.09%6.21%0.93%
Earnings Yield
3.77%3.77%0.80%3.79%0.69%
Efficiency Ratios
Receivables Turnover
8.68 8.68 6.03 7.95 6.54
Payables Turnover
12.87 12.87 5.82 6.57 4.37
Inventory Turnover
2.51 2.51 0.97 1.35 0.78
Fixed Asset Turnover
2.59 2.59 2.64 2.84 2.30
Asset Turnover
0.67 0.67 0.71 0.76 0.60
Working Capital Turnover Ratio
1.67 1.67 1.99 2.01 1.46
Cash Conversion Cycle
158.83 158.83 372.49 260.48 437.67
Days of Sales Outstanding
42.06 42.06 60.50 45.92 55.79
Days of Inventory Outstanding
145.13 145.13 374.75 270.16 465.35
Days of Payables Outstanding
28.36 28.36 62.76 55.60 83.47
Operating Cycle
187.19 187.19 435.24 316.08 521.14
Cash Flow Ratios
Operating Cash Flow Per Share
0.48 0.48 0.19 0.79 0.31
Free Cash Flow Per Share
-0.02 -0.02 -0.07 0.23 -0.29
CapEx Per Share
0.50 0.50 0.26 0.56 0.60
Free Cash Flow to Operating Cash Flow
-0.05 -0.05 -0.38 0.29 -0.92
Dividend Paid and CapEx Coverage Ratio
0.77 0.77 0.28 0.97 0.31
Capital Expenditure Coverage Ratio
0.95 0.95 0.72 1.41 0.52
Operating Cash Flow Coverage Ratio
0.28 0.28 0.10 0.39 0.20
Operating Cash Flow to Sales Ratio
0.10 0.10 0.04 0.14 0.08
Free Cash Flow Yield
-0.49%-0.49%-0.85%2.11%-3.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
26.55 26.55 124.70 26.38 145.16
Price-to-Sales (P/S) Ratio
1.05 1.05 1.68 1.96 2.12
Price-to-Book (P/B) Ratio
1.22 1.22 2.24 2.66 2.12
Price-to-Free Cash Flow (P/FCF) Ratio
-204.29 -204.29 -117.51 47.50 -29.80
Price-to-Operating Cash Flow Ratio
10.43 10.43 45.24 13.78 27.32
Price-to-Earnings Growth (PEG) Ratio
0.15 0.15 -1.49 0.04 -1.95
Price-to-Fair Value
1.22 1.22 2.24 2.66 2.12
Enterprise Value Multiple
8.23 8.23 22.08 13.63 17.76
Enterprise Value
27.73M 27.73M 48.54M 59.24M 45.71M
EV to EBITDA
8.23 8.23 22.08 13.63 17.76
EV to Sales
1.07 1.07 1.97 2.16 2.30
EV to Free Cash Flow
-208.48 -208.48 -137.50 52.15 -32.38
EV to Operating Cash Flow
10.64 10.64 52.93 15.13 29.68
Tangible Book Value Per Share
3.57 3.57 2.92 3.40 3.43
Shareholders’ Equity Per Share
4.10 4.10 3.74 4.10 4.01
Tax and Other Ratios
Effective Tax Rate
0.37 0.37 -0.08 0.30 0.72
Revenue Per Share
4.75 4.75 4.98 5.55 4.01
Net Income Per Share
0.19 0.19 0.07 0.41 0.06
Tax Burden
0.60 0.60 1.08 0.75 0.28
Interest Burden
0.90 0.90 0.64 0.89 0.82
Research & Development to Revenue
0.05 0.05 0.06 0.06 0.07
SG&A to Revenue
0.13 0.13 0.14 0.10 0.12
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
2.55 2.55 2.75 2.06 5.31
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis